10,643
Total Claims
$2.3M
Drug Cost
1,171
Beneficiaries
$1,936
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+27%
Cost per patient vs peers
$1,936 vs $1,524 avg
+47%
Brand preference vs peers
20.0% vs 13.7% avg
Brand vs Generic
80% generic
Brand: 2,132 claims · $2.1M
Generic: 8,511 claims · $197K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 583 | $658K |
| Evolocumab | 508 | $454K |
| Rivaroxaban | 359 | $391K |
| Alirocumab | 191 | $174K |
| Sacubitril/Valsartan | 102 | $139K |
| Dronedarone Hcl | 65 | $81K |
| Empagliflozin | 53 | $52K |
| Dapagliflozin Propanediol | 25 | $34K |
| Ranolazine | 141 | $30K |
| Icosapent Ethyl | 37 | $21K |
| Bempedoic Acid/Ezetimibe | 36 | $19K |
| Metoprolol Succinate | 703 | $19K |
| Ticagrelor | 24 | $18K |
| Ezetimibe | 356 | $16K |
| Atorvastatin Calcium | 992 | $13K |
Prescribing Profile
63
Unique Drugs
$1.3M
Patient Profile
76
Avg Age
48%
Female
1.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data